Alternative Screener Test T15 9/12

The chart shows the growth of an initial investment of $10,000 in Alternative Screener Test T15 9/12, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.

The table below presents the monthly returns of Alternative Screener Test T15 9/12, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.

Alternative Screener Test T15 9/12 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

The current rank of Alternative Screener Test T15 9/12 is 71, indicating average performance compared to other portfolios on our website. Here’s a breakdown of how it compares using common performance measures.

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current Alternative Screener Test T15 9/12 Sharpe ratio is 0.62. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.18 to 0.75, this portfolio's current Sharpe ratio lies between the 25th and 75th percentiles. This indicates that the its risk-adjusted performance is in line with the majority of portfolios. This suggests a balanced approach to risk and return, which might be suitable for a broad range of investors.

Use the chart below to compare the Sharpe ratio of Alternative Screener Test T15 9/12 with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Alternative Screener Test T15 9/12 provided a 1.38% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alternative Screener Test T15 9/12. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alternative Screener Test T15 9/12 was 35.08%, occurring on Mar 23, 2020. Recovery took 97 trading sessions.

The current Alternative Screener Test T15 9/12 drawdown is 12.33%.

The current Alternative Screener Test T15 9/12 volatility is 10.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.